TPX2: Microtubule Nucleation Factor and Key Mitotic Regulator

A comprehensive biomedical overview of TPX2 (TPX2 Microtubule Nucleation Factor), including gene characteristics, expression, mutations, and associated diseases.

Gene Information Card

Symbol TPX2
Full Name TPX2 Microtubule Nucleation Factor
Gene Type Protein-coding
Chromosomal Location 20q11.21
NCBI Gene ID 22974 ncbi.nlm.nih.gov/gene/22974
Ensembl ID ENSG00000088325
UniProt ID Q9ULW0
OMIM ID 605917
HGNC ID 1249
Aliases DIL-2, HCA519, REPP86, p100, C20orf1, DIL2, FLJ10270, GDDR, HCA519, REPP86, TPX2

Description

TPX2 (TPX2 Microtubule Nucleation Factor) encodes a protein essential for mitotic spindle assembly and microtubule nucleation. It activates the Aurora A kinase and targets it to spindle microtubules. TPX2 is overexpressed in various cancers and is implicated in tumorigenesis and chromosomal instability.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer TPX2 overexpression promotes Aurora A activation and mitotic defects, leading to aneuploidy and tumor progression. PubMed: 21502544; COSMIC: TPX2 overexpression in breast tumors.
Lung Cancer TPX2 upregulation correlates with poor prognosis and increased cell proliferation via spindle checkpoint dysregulation. PubMed: 23541953; NCBI Gene: expression data.
Colorectal Cancer TPX2 amplification and overexpression contribute to chromosomal instability and metastasis. PubMed: 25636874; COSMIC: TPX2 mutations in colorectal samples.
Hepatocellular Carcinoma TPX2 overexpression is associated with aggressive tumor features and shortened survival. PubMed: 27323851; UniProt: disease association.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis 38.2 High
Bone Marrow 25.1 High
Lymph Node 18.7 Medium
Spleen 15.3 Medium
Brain 2.1 Low
Heart 1.8 Low
Cell Line Expression
Cell Line nTPM Notes
HeLa (cervical carcinoma) 42.5 High expression; mitotic regulation.
A549 (lung carcinoma) 35.0 Overexpressed; linked to proliferation.
MCF7 (breast carcinoma) 28.3 Elevated; associated with Aurora A.
HepG2 (hepatocellular carcinoma) 30.1 High; correlates with poor prognosis.
K562 (leukemia) 22.4 Moderate expression.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.1072G>A (p.Glu358Lys) Missense <0.1% Unknown functional effect; reported in COSMIC.
c.1543C>T (p.Arg515Trp) Missense <0.1% Potential impact on microtubule binding.
c.1966_1967insA (p.Thr656Asnfs*2) Frameshift <0.1% Loss of function; truncation.
Amplification Copy number gain Common in cancers Overexpression; oncogenic.
Mutation functional classification

Loss of Function (LOF)

Frameshift and nonsense mutations (e.g., p.Thr656Asnfs*2) lead to truncated protein, impairing microtubule nucleation and mitotic spindle assembly.

Gain of Function (GOF)

Gene amplification and overexpression result in increased Aurora A activation, promoting mitotic defects and tumorigenesis.

Dominant Negative (DN)

Not well documented; missense variants may interfere with normal TPX2 function but evidence is limited.

Pathways

• Aurora A signaling (Reactome: R-HSA-8854518)
• Cell Cycle
• Mitotic (Reactome: R-HSA-69278)
• Regulation of TPX2 degradation (Reactome: R-HSA-8852276)
• KEGG: Cell cycle (hsa04110)

Protein Summary

TPX2 is a 747-amino acid protein (UniProt Q9ULW0) that functions as a microtubule nucleation factor. It binds to and activates Aurora A kinase, targeting it to spindle microtubules during mitosis. TPX2 is essential for proper spindle assembly, chromosome segregation, and cytokinesis. Overexpression in cancers leads to mitotic errors and genomic instability.

Related Products

Product name Cat.No. Species Gene ID
No Data
Contact Us
*
*
*
How did you hear about us: